Assistant Professor, Division of Hematology & Oncology, Department of PediatricsEmory University School of Medicine, United States
54: Galectin-9 is a regulator of immune interactions in the tumor microenvironment and represents a novel therapeutic target in biliary tract cancer.
Saturday, March 23, 20248:42am – 8:52am ET